J. Blinco
Papers
3
Total Citations
32
H-Index
3
About
J. Blinco is an innovative researcher working at the intersection of antimicrobial resistance (AMR) surveillance, robotics, and One Health frameworks — an approach that recognizes the interconnected health of humans, animals, and the environment. Blinco's most significant contribution is the development of the Robotic Antimicrobial Susceptibility Platform (RASP), a groundbreaking high-throughput system designed to overcome the chronic scalability limitations that have long constrained traditional AMR surveillance programs. This work, which has attracted 24 citations since its 2021 publication, represents a meaningful technological leap in how resistance patterns can be monitored across large sample populations affordably and efficiently. Building on this foundation, Blinco's subsequent research demonstrated RASP's real-world utility by deploying augmented surveillance to detect the transnational spread of fluoroquinolone-resistant *Escherichia coli* into poultry populations — a finding with direct public health implications given fluoroquinolones' critical importance in human medicine. This work underscores Blinco's commitment to translating technological innovation into actionable biosurveillance intelligence. With a focused but impactful body of work, Blinco is emerging as a valuable contributor to global efforts combating the growing AMR crisis through smarter, scalable monitoring solutions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3